SO
62
-2
DGX
44
-3
AMGN
33
2
XRX
44
2
HCA
48
2
HP
52
2
PSA
61
-2
MTCH
55
2
HAS
37
3
LMT
32
2
SBUX
52
13
APA
30
3
PNW
67
-3
TGT
31
4
SCHW
65
-2
VTR
50
-5
STI
19
-12
KSS
26
3
RIG
61
6
BAX
36
3
SO
62
-2
DGX
44
-3
AMGN
33
2
XRX
44
2
HCA
48
2
HP
52
2
PSA
61
-2
MTCH
55
2
HAS
37
3
LMT
32
2
SBUX
52
13
APA
30
3
PNW
67
-3
TGT
31
4
SCHW
65
-2
VTR
50
-5
STI
19
-12
KSS
26
3
RIG
61
6
BAX
36
3
Financhill
Back

Neurogene Stock Predictions

This Cash Calendar Could Help Ease the Bite of Inflation

Sign up here to claim yours.
Sell
20

NGNE
Neurogene

Last Price:
25.58
Seasonality Move:
25.48%

7 Day Trial

ALL ACCESS PASS

$ 7

The $6 Billion Income Secret of the World's Most Successful Investor

Discover the 3-step trick to finding top dividend stocks to buy and hold forever

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 21.5% based on the past 10 years of stock performance.
  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $25.43. The Score for NGNE is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 21.5% based on the past 10 years of stock performance.

Neurogene Stock Rating

Sell
20
Neurogene (NGNE) is a Sell

Is Neurogene overpriced?

  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
74.49
52-Week Low:
12.49

Prediction Charts

Market Cap:
377.76M
Price in USD:
25.43
Volume:
317.56K
Beta:
-1.26

Technical Analysis

SMA50:
43.45
SMA100:
41.03
SMA200:
38.56
52-Wk Change:
86.44%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 25.43 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-11 70.04 71.53 74.49 69.49
Nov-12 48.28 40.00 49.37 35.60
Nov-13 39.67 39.54 41.33 39.08
Nov-14 39.50 39.20 43.24 38.97
Nov-15 38.84 34.52 39.20 34.52
Nov-18 22.24 19.82 23.79 18.94
Nov-19 20.90 17.23 20.99 17.01
Nov-20 17.31 15.33 17.45 15.28
Nov-21 15.06 15.59 16.15 14.44
Nov-22 15.48 20.30 20.93 15.48
Nov-25 21.05 22.32 22.57 20.50
Nov-26 25.97 26.87 27.61 24.23
Nov-27 27.14 25.80 27.68 24.60
Nov-29 26.71 25.43 26.75 24.78

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.